Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (21-30 of 336) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Prognostic and predictive factors for breast cancer: translating technology to oncologyDaniel F Hayes
The Lancet. Oncology|March 3, 2007
Quantitative measures of oestrogen receptor and ERBB2 expressionDaniel F Hayes
Cell Cycle (Georgetown, Tex.)|March 24, 2009
Cyclin E as a prognostic factor: what is the question?Daniel F Hayes
Breast (Edinburgh, Scotland)|October 22, 2011
Disease related indicators for a proper choice of adjuvant treatmentsDaniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Sitting with grandmaDaniel F Hayes
Breast (Edinburgh, Scotland)|August 5, 2015
Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification for early vs. late recurrencesDaniel F Hayes
JAMA Oncology|December 16, 2017
Precision Medicine and Testing for Tumor Biomarkers-Are All Tests Born Equal?Daniel F Hayes
Journal of the National Cancer Institute|November 6, 2003
Playing the old piano: another tune for endocrine therapy?Daniel F Hayes
BMC Medicine|November 16, 2013
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!Daniel F Hayes
CA: a Cancer Journal for Clinicians|August 15, 2009
Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?Nehmat Houssami, Daniel F Hayes
Pageof 34

Showing results (21-30 of 336) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Prognostic and predictive factors for breast cancer: translating technology to oncologyDaniel F Hayes
The Lancet. Oncology|March 3, 2007
Quantitative measures of oestrogen receptor and ERBB2 expressionDaniel F Hayes
Cell Cycle (Georgetown, Tex.)|March 24, 2009
Cyclin E as a prognostic factor: what is the question?Daniel F Hayes
Breast (Edinburgh, Scotland)|October 22, 2011
Disease related indicators for a proper choice of adjuvant treatmentsDaniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Sitting with grandmaDaniel F Hayes
Breast (Edinburgh, Scotland)|August 5, 2015
Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification for early vs. late recurrencesDaniel F Hayes
JAMA Oncology|December 16, 2017
Precision Medicine and Testing for Tumor Biomarkers-Are All Tests Born Equal?Daniel F Hayes
Journal of the National Cancer Institute|November 6, 2003
Playing the old piano: another tune for endocrine therapy?Daniel F Hayes
BMC Medicine|November 16, 2013
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!Daniel F Hayes
CA: a Cancer Journal for Clinicians|August 15, 2009
Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?Nehmat Houssami, Daniel F Hayes
Pageof 34